ALLO vs ESS · rev $22.0K vs P/E 31, rev $1.89B
Allogene Therapeutics Inc (ALLO) versus Essex Property Trust Inc (ESS) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
Essex Property Trust Inc (ESS) is a reit - residential company listed on NYSE.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
Latest reported ESS revenue for 2025-12-31 was $1.89B. Net income was $702.8M. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. ESS currently screens at market cap $18.91B and trailing P/E 30.9.
ALLO currently screens at market cap $258.1M. ESS currently screens at market cap $18.91B and trailing P/E 30.9.
Not investment advice. Open the ALLO and ESS stock pages for the full models.
Not investment advice.